Clinico-pathological characterization of hepatitis C virus-related B- cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia

Annals of Oncology

Volumn 9, Issue 5, 1998, Pages 495-498

  Luppi, M ^a   Longo, G ^a   Ferrari, M G ^a   Barozzi, P ^a   Marasca, R ^a   Morselli, M ^a   Valenti, C ^a   Mascia, T ^a   Vandelli, L ^a   Vallisa, D ^b   Cavanna, L ^b   Torelli, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Section of Hematology   (Italy)

Author keywords

B cell non Hodgkin's lymphoma; HCV; Mixed cryoglobulinemia type II

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CRYOGLOBULINEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 7144250529     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008255830453     Document Type: Article

References (24)

1. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
2. Pozzato G, Mazzaro C, Crovatto M et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-53.
3. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-4.
4. Luppi M, Ferrari MG, Bonaccorsi G et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351 5.
5. Pioltelli P, Zehender G, Monti G et al. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 624 5 (Letter).
6. De Vita S, Sacco C, Sansonno D et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-82.
7. Harris NL, Jaffe ES, Stein H et al. A revised European American classification of lymphoid neoplasms. A proposal from the International lymphoma study Group. Blood 1994; 84: 1361 92.
8. Nie NH, Hadlai HC, Jenkins JG et al. Statistical Package for the Social Sciences. New York: McGraw-Hill 1979.
9. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 1. Introduction and design. Br J Cancer 1976; 34: 585-612.
10. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology. 1994; 20: 1442 9.
11. Izumi T, Sasaki R, Miura Y et al. B-cell malignacy and hepatitis C virus infection. Leuk Res 1996; 20: 445 (Letter).
12. Zuckerman T, Zuckerman E, Douer D et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Blood 1996; 88: 222a (Abstr).
13. Hanley J, Jarvis L, Simmonds P et al. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 1339 (Letter).
14. McColl MD, Campbell Tait R, Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Haematol 1996; 92: 771-2 (Letter).
15. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-301.
16. Mazzaro C, Zagonel V, Monfardini S et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-50.
17. Rickinson AB, Kieff E, Epstein-Barr virus. In Fields BN, Knipe DM, Howley PM, ChanockRM, Melnick JL, Monath TP, Roizman B, Straus SE (eds): Virology. 3rd edition. Philadelphia: Lippincott-Raven 1996; 2397-446.
18. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus non-structural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 3893-6.
19. Ray RB, Lagging M, Meyer K et al. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996; 70: 4438-43.
20. Luppi M, Longo G, Ferrari MG et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94: 373-5.
21. De Vita S, Sansonno D, Dolcetti R et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887-92.
22. Luppi M, Ferrari MG, Torelli G. HCV genotype distribution in B-NHL. Ann Intern Med 1997 (in press).
23. Bellary S, Schiano T, Hartman G et al. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: Favorable response to prednisone and azathioprine. Ann Intern Med 1995; 123: 32-4.
24. Vento S, Cainelli F, Mirandola F et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 92-3.